We performed IHC on a TMA including 231 primary tumors from patients with metastatic breast cancer, to identify T lymphocytes (CD3+ cells), macrophages (CD68+ cells), and neutrophils (NE+ cells) (Fig. 1). The gene discussed is CD68; the disease is breast cancer.